Ellevest, Inc. Novartis Ag Transaction History

Ellevest, Inc.

$1.48 Billion
Q1 2025

A detailed history of Ellevest, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Ellevest, Inc. holds 11,137 shares of NVS stock, worth $1.29 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

11,137

Previous 15,970 30.26%

Holding current value

$1.29 Million

Previous $1.55 Million 20.14%

% of portfolio

0.08%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$97.14 - $115.57 $469,477 - $558,549	-4,833 Reduced 30.26%	11,137 $1.24 Million
Q4 2024 Feb 14, 2025	SELL	$96.78 - $117.18 $225,110 - $272,560	-2,326 Reduced 12.71%	15,970 $1.55 Million
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $9,976 - $11,363	94 Added 0.52%	18,296 $2.1 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $180,696 - $209,586	1,952 Added 12.01%	18,202 $1.94 Million
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $112,132 - $127,669	1,177 Added 7.81%	16,250 $1.57 Million
Q4 2023 Feb 06, 2024	BUY	$92.27 - $101.54 $41,060 - $45,185	445 Added 3.04%	15,073 $1.52 Million
Q3 2023 Nov 09, 2023	BUY	$94.73 - $105.13 $178,660 - $198,275	1,886 Added 14.8%	14,628 $1.49 Million
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $121,386 - $137,641	1,312 Added 11.48%	12,742 $1.29 Million
Q1 2023 May 04, 2023	BUY	$80.03 - $92.81 $88,433 - $102,555	1,105 Added 10.7%	11,430 $1.05 Million
Q4 2022 Feb 03, 2023	BUY	$75.55 - $92.52 $329,926 - $404,034	4,367 Added 73.3%	10,325 $936,000
Q3 2022 Nov 02, 2022	SELL	$74.61 - $87.26 $361,560 - $422,861	-4,846 Reduced 44.85%	5,958 $453,000
Q2 2022 Jul 18, 2022	BUY	$80.52 - $93.75 $150,894 - $175,687	1,874 Added 20.99%	10,804 $913,000
Q1 2022 Apr 19, 2022	BUY	$80.11 - $90.62 $128,977 - $145,898	1,610 Added 21.99%	8,930 $784,000
Q4 2021 Jan 24, 2022	SELL	$79.7 - $88.13 $19,128 - $21,151	-240 Reduced 3.17%	7,320 $640,000
Q3 2021 Oct 19, 2021	BUY	$81.78 - $95.14 $137,390 - $159,835	1,680 Added 28.57%	7,560 $618,000
Q2 2021 Jul 13, 2021	BUY	$85.24 - $94.15 $73,391 - $81,063	861 Added 17.15%	5,880 $536,000
Q1 2021 May 03, 2021	BUY	$83.5 - $98.47 $74,899 - $88,327	897 Added 21.76%	5,019 $429,000
Q4 2020 Feb 04, 2021	BUY	$78.07 - $94.43 $95,089 - $115,015	1,218 Added 41.94%	4,122 $389,000
Q3 2020 Oct 26, 2020	BUY	$82.14 - $91.0 $3,203 - $3,549	39 Added 1.36%	2,904 $253,000
Q2 2020 Jul 06, 2020	BUY	$80.93 - $91.1 $94,526 - $106,404	1,168 Added 68.83%	2,865 $250,000
Q1 2020 Apr 13, 2020	BUY	$70.67 - $99.01 $69,397 - $97,227	982 Added 137.34%	1,697 $140,000
Q4 2019 Feb 05, 2020	BUY	$84.35 - $95.37 $59,044 - $66,759	700 Added 4666.67%	715 $68,000
Q3 2019 Oct 08, 2019	SELL	$85.54 - $94.26 $9,666 - $10,651	-113 Reduced 88.28%	15 $1,000
Q2 2019 Aug 20, 2019	BUY	$75.4 - $92.8 $9,651 - $11,878	128 New	128 $12,000

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account